Ranbaxy Files Corrective Action Plan with FDA
Ranbaxy Files Corrective Action Plan. Generic drug maker Ranbaxy Laboratories LTD has filed a corrective action plan with the U.S. Food & Drug Administration (FDA). The FDA barred some of [...]